Investment
Features
FeesSafety
Academy
More
Pluang+

Class action alleges Cogent misled investors on pledged-share risks before stock plunged 80%.

Market News
03 Sep 2026
PRNewsWire
View Source
Bearish
pluang ai news

A class action lawsuit has been filed against Cogent Communications Holdings, accusing the company of misleading investors about the risks related to pledged shares and margin loans. The complaint claims Cogent's SEC filings warned generally about foreclosure risks but failed to disclose the material risk of forced stock sales, which contributed to an over 80% stock price drop from $86 to under $17. The lawsuit highlights a significant $82.5 million forced sale of pledged shares by lenders in 2025, which allegedly disrupted the market. Investors who bought Cogent securities between February 2024 and May 2026 may seek to join the case, with a lead plaintiff deadline of September 21, 2026.

More News

Lands' End Q2 revenue beats estimates, EPS slightly misses; balance sheet improves but liquidity cautious.

Lands' End Q2 revenue beats estimates, EPS slightly misses; balance sheet improves but liquidity cautious.

Lands' End reported Q2 fiscal results with revenue rising 2.7% to $302 million, beating analyst expectations, while adjusted EPS missed slightly at $0.09 versus $0.10 forecast. The company improved profitability from a year ago, turning an adjusted l...

Company Fundamentals
Neutral
1 hour ago
Planet Labs Q2 earnings expected to improve losses by 33%, with strong backlog growth signaling future potential.

Planet Labs Q2 earnings expected to improve losses by 33%, with strong backlog growth signaling future potential.

Planet Labs is set to report its Q2 earnings, with analysts expecting a loss of $0.02 per share, a 33.3% improvement from last year. Revenue is estimated at $104.12 million. Despite a significant stock decline, trading 27% below its 200-day average, ...

Company Fundamentals
Neutral
1 hour ago
CVS Health raises revenue forecast after strong Q2, analysts see 21-28% stock upside.

CVS Health raises revenue forecast after strong Q2, analysts see 21-28% stock upside.

CVS Health reported a 7.3% revenue increase in Q2 to $106.1 billion and raised its full-year revenue forecast to at least $414 billion, alongside improved earnings per share guidance. Despite UBS lowering its price target to $118, analysts like Jeffe...

Analyst Insights
Bullish
2 hours ago
Zscaler earnings preview focuses on AI security growth and cautious fiscal 2027 guidance.

Zscaler earnings preview focuses on AI security growth and cautious fiscal 2027 guidance.

Zscaler is set to report earnings with an expected EPS of $1.09 and revenue near $877 million, reflecting about 22% growth year-over-year. Investors are closely watching the company's fiscal 2027 guidance after a previous outlook caused a sharp 31.52...

Company Fundamentals
Bullish
2 hours ago
Canaccord lowers Gold.com's price target despite strong FY26 growth, citing weak Q4 results.

Canaccord lowers Gold.com's price target despite strong FY26 growth, citing weak Q4 results.

Canaccord Genuity maintained a Buy rating on Gold.com but reduced its price target from $70 to $65 due to weaker-than-expected fourth-quarter results. Gold.com reported a strong fiscal 2026 with revenue up 132% to $25.51 billion and net income rising...

Analyst Insights
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App